In the study, 50 cardiac surgery patients used the ECG-equipped Apple Watch for heart rhythm readings three times per day for two days. The readings were evaluated for occurrences of atrial fibrillation both by the Apple Watch’s own technology and by a cardiologist’s assessment of the accompanying PDF printout of waveform strips generated by the Apple Health app.
While the Apple Watch alone only detected 41 percent of the patients’ instances of AFib, cardiologists were able to do so from the wearable-generated PDF 98 percent of the time. There were no false positives generated by either evaluation method, and the ECG detected all AFib instances, proving that the Apple Watch ECG is a powerful diagnostic aid, but certainly not a stand-in for physicians.
“The data suggests that further technological advances are necessary before these wearables can be fully incorporated into current clinical management,” Milind Desai, MD, a Cleveland Clinic cardiologist and director of clinical operations in the department of cardiovascular medicine, said in a statement.
More articles on health IT:
Inside Google’s contract to gather de-identified patient data from UCSF for free: Stat
16 hospitals, health systems seeking Allscripts, Cerner, Epic, Meditech talent
Rady Children’s notifies 2,360 patients of internet port that exposed their information
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.